Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study
Year: 2025
Type: article
Language: en
Topic: Inflammatory Biomarkers in Disease Prognosis
Authors and affiliations:
raw_author_name: Risako Suzuki
raw_affiliation_strings: Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan
Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo 142-8555, Japan
raw_author_name: Ryotaro Ohkuma
raw_affiliation_strings: Comprehensive Cancer Information Center, Showa Medical University, Tokyo 142-8555, Japan
Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan
Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
raw_author_name: Makoto Watanabe
raw_affiliation_strings: Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan
Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan
Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo 142-8555, Japan
Pharmacological Research Center, Showa Medical University, Tokyo 142-8555, Japan
raw_author_name: Emiko Mura
raw_affiliation_strings: Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
raw_author_name: Toshiaki Tsurui
raw_affiliation_strings: Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
raw_author_name: Nana Iriguchi
raw_affiliation_strings: Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
raw_author_name: Tomoyuki Ishiguro
raw_affiliation_strings: Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
raw_author_name: Yuya Hirasawa
raw_affiliation_strings: Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
raw_author_name: Go Ikeda
raw_affiliation_strings: Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
raw_author_name: Masahiro Shimokawa
raw_affiliation_strings: Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
raw_author_name: Hirotsugu Ariizumi
raw_affiliation_strings: Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
raw_author_name: Yutaro Kubota
raw_affiliation_strings: Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
raw_author_name: Kiyoshi Yoshimura
raw_affiliation_strings: Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan
Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan
Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
raw_author_name: Shinichi Kobayashi
raw_affiliation_strings: Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan
raw_author_name: Takuya Tsunoda
raw_affiliation_strings: Comprehensive Cancer Information Center, Showa Medical University, Tokyo 142-8555, Japan
Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
raw_author_name: Atsushi Horiike
raw_affiliation_strings: Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
raw_author_name: Mayumi Tsuji
raw_affiliation_strings: Pharmacological Research Center, Showa Medical University, Tokyo 142-8555, Japan
raw_author_name: Yuji Kiuchi
raw_affiliation_strings: Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo 142-8555, Japan
Pharmacological Research Center, Showa Medical University, Tokyo 142-8555, Japan
raw_author_name: Tatsunori Oguchi
raw_affiliation_strings: Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo 142-8555, Japan
Pharmacological Research Center, Showa Medical University, Tokyo 142-8555, Japan
raw_author_name: Satoshi Wada
raw_affiliation_strings: Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan
Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo 157-8577, Japan
Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan
Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo 142-8555, Japan